Document is current
Any future updates will be listed below
-
Authors
Birdwell, Christine E.
Fiskus, Warren https://orcid.org/0000-0002-7343-6214
Kadia, Tapan M. https://orcid.org/0000-0002-9892-9832
Mill, Christopher P. https://orcid.org/0000-0003-0957-6009
Sasaki, Koji https://orcid.org/0000-0002-9140-0610
Daver, Naval https://orcid.org/0000-0001-7103-373X
DiNardo, Courtney D. https://orcid.org/0000-0001-9003-0390
Pemmaraju, Naveen https://orcid.org/0000-0002-1670-6513
Borthakur, Gautam https://orcid.org/0000-0001-7679-6453
Davis, John A.
Das, Kaberi https://orcid.org/0000-0003-4702-0386
Sharma, Sunil
Horrigan, Stephen
Ruan, Xinjia
Su, Xiaoping
Khoury, Joseph D. https://orcid.org/0000-0003-2621-3584
Kantarjian, Hagop
Bhalla, Kapil N. https://orcid.org/0000-0001-5209-5126
- License Information
-
More Information
Article History
Received: 18 June 2023
Revised: 27 November 2023
Accepted: 29 November 2023
First Online: 12 December 2023
Competing interests
: SH is the Chief Scientific Officer at Iterion Therapeutics. KNB has served as a consultant to Iterion Therapeutics. All other authors declare they have no conflict of interest to disclose.
